Gene · 4837
Papers1,489
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,489
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Increasing cellular NAD+ protects hepatocytes against palmitate-induced lipotoxicity by preventing PARP-1 inhibition and the mTORC1-p300 pathway activation. | Am J Physiol Cell Physiol | 2025 | 39871470 | PubTator, text mining | PubMed |
| Nicotinamide n-methyltransferase inhibitor synergizes with sodium-glucose cotransporter 2 inhibitor to protect renal tubular epithelium in experimental models of type 2 diabetes mellitus. | J Diabetes Complications | 2025 | 39848127 | PubTator, text mining | PubMed |
| Proteomics unveil candidate biomarkers and pathogenesis of subacute thyroiditis. | Endocr Connect | 2025 | 39807704 | PubTator, text mining | PubMed |
| Single-cell RNA-sequencing and genome-wide Mendelian randomisation along with abundant machine learning methods identify a novel B cells signature in gastric cancer. | Discov Oncol | 2025 | 39760915 | PubTator, text mining | PubMed |
| NNMT suppresses H3K9me3 to facilitate malignant progression and drug resistance in gastric cancer. | Arab J Gastroenterol | 2025 | 39757078 | PubTator, text mining | PubMed |
| m6A demethylation of NNMT in CAFs promotes gastric cancer progression by enhancing macrophage M2 polarization. | Cancer Lett | 2025 | 39725153 | PubTator, text mining | PubMed |
| Genetic inhibition of nicotinamide N-methyltransferase and prevention of alcohol-associated fatty liver in humans. | J Hum Genet | 2025 | 39695269 | PubTator, text mining | PubMed |
| Nicotinamide N-methyltransferase negatively regulates metastasis-promoting property of cancer-associated fibroblasts in lung adenocarcinoma. | Cancer Commun (Lond) | 2025 | 39623600 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing and immune microenvironment analysis reveal PLOD2-driven malignant transformation in cervical cancer. | Front Immunol | 2024 | 39840054 | PubTator, text mining | PubMed |
| PI(4,5)P2 alleviates colitis by inhibiting intestinal epithelial cell pyroptosis through NNMT-mediated RBP4 m6A modification. | Cell Death Dis | 2024 | 39706833 | PubTator, text mining | PubMed |
| Exploring NNMT: from metabolic pathways to therapeutic targets. | Arch Pharm Res | 2024 | 39604638 | PubTator, text mining | PubMed |
| Transformation of peptides to small molecules in medicinal chemistry: Challenges and opportunities. | Acta Pharm Sin B | 2024 | 39525591 | PubTator, text mining | PubMed |
| Overexpressed nicotinamide N‑methyltransferase in endometrial stromal cells induced by macrophages and estradiol contributes to cell proliferation in endometriosis. | Cell Death Discov | 2024 | 39489776 | PubTator, text mining | PubMed |
| A systematic evaluation of quenching, extraction and analysis procedures for metabolomics study of the mechanism of QYSLD intervention in A549 cells. | Anal Bioanal Chem | 2024 | 39467912 | PubTator, text mining | PubMed |
| Consensus Clustering Analysis Identifies Ferroptosis-Related Patient Clusters and Predictive Signature Construction Based on Ferroptosis-Related Genes in Ischemic Cardiomyopathy. | J Inflamm Res | 2024 | 39372582 | PubTator, text mining | PubMed |
| Nicotinamide N-methyltransferase (NNMT): A key enzyme in cancer metabolism and therapeutic target. | Int Immunopharmacol | 2024 | 39312861 | PubTator, text mining | PubMed |
| NNMT overexpression is an adverse prognostic factor in uterine leiomyosarcoma. | Turk J Med Sci | 2024 | 39295619 | PubTator, text mining | PubMed |
| A Supramolecular Biosensor for Rapid and High-Throughput Quantification of a Disease-Associated Niacin Metabolite. | Anal Chem | 2024 | 39183562 | PubTator, text mining | PubMed |
| Nicotinamide N-methyltransferase inhibition mitigates obesity-related metabolic dysfunction. | Diabetes Obes Metab | 2024 | 39161060 | PubTator, text mining | PubMed |
| Identifying polyamine related biomarkers in diagnosis and treatment of ulcerative colitis by integrating bulk and single-cell sequencing data. | Sci Rep | 2024 | 39103474 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4837/papers?page=7